Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial – PACHA-01 (NCT02494973)

被引：0
|
作者：
Diane Goéré
Jean-Pierre Pignon
Maximiliano Gelli
Dominique Elias
Léonor Benhaim
Frédéric Deschamps
Caroline Caramella
Valérie Boige
Michel Ducreux
Thierry de Baere
David Malka
机构：
[1] Department of Surgical Oncology - Gustave Roussy,Centre for Research in Epidemiology and Population Health (team 2), INSERM U1018
[2] Statistics and Epidemiology Unit - Gustave Roussy,undefined
[3] Paris-Saclay University,undefined
[4] Department of Interventional Radiology - Gustave Roussy,undefined
[5] Department of Radiology - Gustave Roussy,undefined
[6] Department of Cancer Medicine - Gustave Roussy,undefined
来源：
BMC Cancer | / 18卷
关键词：
Colorectal cancer; Liver metastases; Liver resection; Adjuvant chemotherapy; Hepatic arterial infusion; Oxaliplatin; Randomized trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 33 条
  • [21] mFOLFIRINOX versus mFOLFOX 6 as adjuvant treatment for high-risk stage III colon cancer - the FROST trial: study protocol for a multicenter, randomized controlled, phase II trial
    Kyung-Ha Lee
    In Jun Yang
    Gi Won Ha
    Jaeim Lee
    Youn Young Park
    Suk Hwan Lee
    Jong Min Lee
    Jung Hoon Bae
    Eun Jung Park
    Hyungjin Kim
    Keun Young Kim
    Sanghyung An
    Ik Yong Kim
    Ji Yeon Kim
    BMC Cancer, 24
  • [22] Safety analysis of two different regimens of uracil-tegafur plus leucovorin as adjuvant chemotherapy for high-risk stage II and III colon cancer in a phase III trial comparing 6 with 18 months of treatment: JFMC33-0502 trial
    Tsuchiya, Takashi
    Sadahiro, Sotaro
    Sasaki, Kazuaki
    Kondo, Ken
    Katsumata, Kenji
    Nishimura, Genichi
    Kakeji, Yoshihiro
    Baba, Hideo
    Morita, Takayuki
    Koda, Keiji
    Sato, Seiji
    Matsuoka, Junji
    Yamaguchi, Yoshiyuki
    Usuki, Hisashi
    Hamada, Chikuma
    Kodaira, Susumu
    Saji, Shigetoyo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (06) : 1253 - 1261
  • [23] Randomized phase II study of tegafur–uracil/leucovorin versus tegafur–uracil/leucovorin plus oxaliplatin after curative resection of high-risk stage II/III colorectal cancer (SOAC-1101 trial)
    Chihiro Kosugi
    Keiji Koda
    Nobuhiro Takiguchi
    Satoru Takaishi
    Hideaki Miyauchi
    Nobuo Hirayama
    Yukihiro Nomura
    Eisuke Kondo
    Yohei Kawasaki
    Yoshihito Ozawa
    Hisahiro Matsubara
    International Journal of Colorectal Disease, 2021, 36 : 1739 - 1749
  • [24] A Randomized Phase II Trial of Three Intensified Chemotherapy Regimens in First-Line Treatment of Colorectal Cancer Patients with Initially Unresectable or Not Optimally Resectable Liver Metastases. The METHEP Trial
    Marc Ychou
    Michel Rivoire
    Simon Thezenas
    François Quenet
    Jean-Robert Delpero
    Christine Rebischung
    Christian Letoublon
    Rosine Guimbaud
    Eric Francois
    Michel Ducreux
    Françoise Desseigne
    Jean-Michel Fabre
    Eric Assenat
    Annals of Surgical Oncology, 2013, 20 : 4289 - 4297
  • [25] ctDNA guided adjuvant chemotherapy versus standard of care adjuvant chemotherapy after curative surgery in patients with high risk stage II or stage III colorectal cancer: a multi-centre, prospective, randomised control trial (TRACC Part C)
    Susanna Slater
    Annette Bryant
    Hsiang-Chi Chen
    Ruwaida Begum
    Isma Rana
    Maria Aresu
    Clare Peckitt
    Oleg Zhitkov
    Retchel Lazaro-Alcausi
    Victoria Borja
    Rachel Powell
    David Lowery
    Michael Hubank
    Thereasa Rich
    Gayathri Anandappa
    Ian Chau
    Naureen Starling
    David Cunningham
    BMC Cancer, 23
  • [26] A Randomized Phase II Trial of Three Intensified Chemotherapy Regimens in First-Line Treatment of Colorectal Cancer Patients with Initially Unresectable or Not Optimally Resectable Liver Metastases. The METHEP Trial
    Ychou, Marc
    Rivoire, Michel
    Thezenas, Simon
    Quenet, Francois
    Delpero, Jean-Robert
    Rebischung, Christine
    Letoublon, Christian
    Guimbaud, Rosine
    Francois, Eric
    Ducreux, Michel
    Desseigne, Francoise
    Fabre, Jean-Michel
    Assenat, Eric
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (13) : 4289 - 4297
  • [27] ctDNA guided adjuvant chemotherapy versus standard of care adjuvant chemotherapy after curative surgery in patients with high risk stage II or stage III colorectal cancer: a multi-centre, prospective, randomised control trial (TRACC Part C)
    Slater, Susanna
    Bryant, Annette
    Chen, Hsiang-Chi
    Begum, Ruwaida
    Rana, Isma
    Aresu, Maria
    Peckitt, Clare
    Zhitkov, Oleg
    Lazaro-Alcausi, Retchel
    Borja, Victoria
    Powell, Rachel
    Lowery, David
    Hubank, Michael
    Rich, Thereasa
    Anandappa, Gayathri
    Chau, Ian
    Starling, Naureen
    Cunningham, David
    BMC CANCER, 2023, 23 (01)
  • [28] Randomized phase II study of tegafur-uracil/leucovorin versus tegafur-uracil/leucovorin plus oxaliplatin after curative resection of high-risk stage II/III colorectal cancer (SOAC-1101 trial)
    Kosugi, Chihiro
    Koda, Keiji
    Takiguchi, Nobuhiro
    Takaishi, Satoru
    Miyauchi, Hideaki
    Hirayama, Nobuo
    Nomura, Yukihiro
    Kondo, Eisuke
    Kawasaki, Yohei
    Ozawa, Yoshihito
    Matsubara, Hisahiro
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2021, 36 (08) : 1739 - 1749
  • [29] A randomized two arm phase III study in patients post radical resection of liver metastases of colorectal cancer to investigate bevacizumab in combination with capecitabine plus oxaliplatin (CAPOX) vs CAPOX alone as adjuvant treatment
    Nikol Snoeren
    Emile E Voest
    Andre M Bergman
    Otilia Dalesio
    Henk M Verheul
    Rob AEM Tollenaar
    Joost RM van der Sijp
    Sander B Schouten
    Inne HM Borel Rinkes
    R van Hillegersberg
    BMC Cancer, 10
  • [30] S-1 and Oxaliplatin Versus Tegafur-uracil and Leucovorin as Postoperative Adjuvant Chemotherapy in Patients With High-risk Stage III Colon Cancer (ACTS-CC 02): A Randomized, Open-label, Multicenter, Phase III Superiority Trial
    Sunami, Eiji
    Kusumoto, Tetsuya
    Ota, Mitsuyoshi
    Sakamoto, Yoshiyuki
    Yoshida, Kazuhiro
    Tomita, Naohiro
    Maeda, Atsuyuki
    Teshima, Jin
    Okabe, Michio
    Tanaka, Chihiro
    Yamauchi, Junichiro
    Itabashi, Michio
    Kotake, Kenjiro
    Takahashi, Keiichi
    Baba, Hideo
    Boku, Narikazu
    Aiba, Keisuke
    Ishiguro, Megumi
    Morita, Satoshi
    Takenaka, Naruhito
    Okude, Ryota
    Sugihara, Kenichi
    CLINICAL COLORECTAL CANCER, 2020, 19 (01) : 22 - +
1234